Ju-Hee Sohn

Title: Ju-Hee Sohn: Innovator in Benzamide Derivatives

Introduction

Ju-Hee Sohn is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on benzamide derivatives. His research focuses on developing compounds that can effectively interact with 5-HT receptors, which are crucial in various therapeutic applications.

Latest Patents

Ju-Hee Sohn holds a patent for a novel benzamide derivative or a pharmaceutically acceptable salt thereof. This invention includes a method for preparing the compound and a 5-HT receptor agonist that contains it as an active ingredient. The benzamide derivatives developed by Sohn exhibit superior affinity for 5-HT receptors, a capability to reduce gastric emptying time, and low toxicity. Consequently, these compounds are therapeutically effective for treating a variety of diseases associated with 5-HT receptors.

Career Highlights

Sohn is currently associated with Dong-a Pharm. Co., Ltd., where he continues to advance his research and development efforts. His work has positioned him as a key figure in the pharmaceutical industry, particularly in the area of drug development targeting serotonin receptors.

Collaborations

Ju-Hee Sohn has collaborated with notable colleagues, including Soon-Hoe Kim and Weon-Bin Im. These partnerships have enhanced his research capabilities and contributed to the successful development of his patented innovations.

Conclusion

Ju-Hee Sohn's contributions to the field of pharmaceuticals, particularly through his work on benzamide derivatives, highlight his role as an influential inventor. His innovative approaches have the potential to lead to significant advancements in the treatment of diseases related to 5-HT receptors.